Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{$index + 1}}. {{ watchedTerm.term }} ({{watchedTerm.accId}})
{{gene.symbol}}: {{ gene.description }}
Save what matters to you
{{ loginError }}
Sign in with your RGD account
Gene: Mir30e (microRNA 30e) Mus musculus
Analyze
Symbol:
Mir30e
Name:
microRNA 30e
RGD ID:
1608216
MGI Page
MGI
Description:
Is expressed in liver. Orthologous to human MIR30E (microRNA 30e).
Type:
ncrna
RefSeq Status:
PROVISIONAL
Also known as:
mir-30e; Mirn; Mirn30e; mmu-mir-3; mmu-mir-30e
RGD Orthologs
Alliance Genes
More Info
more info ...
More Info
Latest Assembly:
GRCm38 - Mouse Genome Assembly GRCm38
Position:
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 120,629,803 - 120,629,894 (-) NCBI GRCm39 mm39 GRCm39 Ensembl 4 120,629,803 - 120,629,894 (-) Ensembl GRCm38 4 120,772,606 - 120,772,697 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 120,772,606 - 120,772,697 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 120,445,211 - 120,445,302 (-) NCBI GRCm37 mm9 NCBIm37 Celera 4 119,490,804 - 119,490,895 (-) NCBI Celera Cytogenetic Map 4 D2.1 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Imported Disease Annotations - CTD
(+)-schisandrin B multiple interactions ISO RGD:2325460 6480464 schizandrin B inhibits the reaction [TGFB1 protein results in decreased expression of MIR30E mRNA] CTD PMID:31697999 (+)-schisandrin B multiple interactions ISO RGD:1354313 6480464 MIR30E mRNA affects the reaction [schizandrin B inhibits the reaction [TGFB1 protein results in increased expression of COL1A1 mRNA]] more ... CTD PMID:31697999 1,3,5-trinitro-1,3,5-triazinane increases expression EXP 6480464 cyclonite results in increased expression of MIR30E mRNA, cyclonite results in increased expression of MIR30E mRNA modified form CTD PMID:19270793 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1354313 6480464 Tetrachlorodibenzodioxin results in increased expression of MIR30E mRNA CTD PMID:30096437 2-hydroxypropanoic acid increases expression ISO RGD:1354313 6480464 Lactic Acid results in increased expression of MIR30E mRNA CTD PMID:30851411 aflatoxin B1 decreases expression ISO RGD:2325460 6480464 Aflatoxin B1 results in decreased expression of MIR30E mRNA CTD PMID:24472605 all-trans-retinoic acid multiple interactions ISO RGD:1354313 6480464 [Tretinoin co-treated with Phenylbutyrates co-treated with 1-hydroxy-2-oxo-3, 3-bis2-aminoethyl-1-triazene] results in increased expression of MIR30E mRNA CTD PMID:23284745 bis(2-chloroethyl) sulfide decreases expression EXP 6480464 Mustard Gas results in decreased expression of MIR30E mRNA CTD PMID:26456178 bis(2-ethylhexyl) phthalate affects expression ISO RGD:2325460 6480464 Diethylhexyl Phthalate affects the expression of MIR30E mRNA CTD PMID:28192093 bisphenol A increases methylation ISO RGD:2325460 6480464 bisphenol A results in increased methylation of MIR30E gene CTD PMID:28505145 bleomycin A2 decreases expression ISO RGD:2325460 6480464 Bleomycin results in decreased expression of MIR30E mRNA CTD PMID:25933445 cadmium dichloride decreases expression ISO RGD:1354313 6480464 Cadmium Chloride results in decreased expression of MIR30E mRNA CTD PMID:30998937 cadmium dichloride multiple interactions ISO RGD:1354313 6480464 MIR30E mRNA inhibits the reaction [Cadmium Chloride results in increased expression of SNAI1 mRNA], MIR30E mRNA inhibits the reaction [Cadmium Chloride results in increased expression of SNAI1 protein] CTD PMID:30998937 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIR30E mRNA CTD PMID:20548288 cisplatin increases expression ISO RGD:2325460 6480464 Cisplatin results in increased expression of MIR30E mRNA CTD PMID:24880025 cyclosporin A decreases expression ISO RGD:1354313 6480464 Cyclosporine results in decreased expression of MIR30E mRNA CTD PMID:27989131 dibutyl phthalate decreases expression ISO RGD:2325460 6480464 Dibutyl Phthalate results in decreased expression of MIR30E mRNA CTD PMID:30934153 ethanol decreases expression EXP 6480464 Ethanol results in decreased expression of MIR30E mRNA CTD PMID:19091803 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIR30E mRNA CTD PMID:20548288 hydrogen peroxide increases expression ISO RGD:1354313 6480464 Hydrogen Peroxide results in increased expression of MIR30E mRNA CTD PMID:26339600 icariin increases expression EXP 6480464 icariin results in increased expression of MIR30E mRNA CTD PMID:30533443 isoprene decreases expression ISO RGD:1354313 6480464 isoprene analog results in decreased expression of MIR30E mRNA CTD PMID:31765140 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of MIR30E mRNA CTD PMID:20548288 methapyrilene affects expression ISO RGD:2325460 6480464 Methapyrilene affects the expression of MIR30E mRNA CTD PMID:24863736 nitrogen dioxide multiple interactions EXP 6480464 [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR30E mRNA CTD PMID:30090456 paracetamol increases expression ISO RGD:2325460 6480464 Acetaminophen results in increased expression of MIR30E mRNA CTD PMID:27397436 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of MIR30E mRNA CTD PMID:19246379 progesterone decreases expression ISO RGD:1354313 6480464 Progesterone results in decreased expression of MIR30E mRNA CTD PMID:22950660 quartz decreases expression ISO RGD:2325460 6480464 Quartz results in decreased expression of MIR30E mRNA CTD PMID:23208435 rac-lactic acid increases expression ISO RGD:1354313 6480464 Lactic Acid results in increased expression of MIR30E mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of MIR30E mRNA CTD PMID:25280562 resveratrol decreases expression ISO RGD:1354313 6480464 resveratrol results in decreased expression of MIR30E mRNA CTD PMID:20637737 sodium arsenite increases expression ISO RGD:1354313 6480464 sodium arsenite results in increased expression of MIR30E mRNA CTD PMID:27054085 , PMID:29207610 sodium fluoride increases expression EXP 6480464 Sodium Fluoride results in increased expression of MIR30E mRNA CTD PMID:29127033 sulfur dioxide multiple interactions EXP 6480464 [Particulate Matter co-treated with Sulfur Dioxide co-treated with Nitrogen Dioxide] results in increased expression of MIR30E mRNA CTD PMID:30090456 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of MIR30E mRNA CTD PMID:25912033 thalidomide decreases expression EXP 6480464 Thalidomide results in decreased expression of MIR30E mRNA CTD PMID:26217789 zinc atom decreases expression ISO RGD:2325460 6480464 Zinc deficiency results in decreased expression of MIR30E mRNA CTD PMID:22689922 zinc(0) decreases expression ISO RGD:2325460 6480464 Zinc deficiency results in decreased expression of MIR30E mRNA CTD PMID:22689922
Biological Process
cellular response to amino acid stimulus acts_upstream_of_or_within IDA 2290270 MGI:4833768 , PMID:20548288 MGI MGI:4833768 , PMID:20548288 cellular response to ethanol acts_upstream_of_or_within IEP 2290270 MGI:3835907 , PMID:19091803 MGI MGI:3835907 , PMID:19091803 cellular response to forskolin acts_upstream_of_or_within IEP 2290270 MGI:5305371 , PMID:21993888 MGI MGI:5305371 , PMID:21993888 cellular response to inorganic substance acts_upstream_of_or_within IDA 2290270 MGI:5305371 , PMID:21993888 MGI MGI:5305371 , PMID:21993888 long-term synaptic potentiation acts_upstream_of_or_within IEP 2290270 MGI:5645435 , PMID:25858512 MGI MGI:5645435 , PMID:25858512 response to bacterium acts_upstream_of_or_within IEP 2290270 MGI:5566744 , PMID:24205035 MGI MGI:5566744 , PMID:24205035 response to oxygen levels acts_upstream_of_or_within IDA 2290270 MGI:3842072 , PMID:19188439 MGI MGI:3842072 , PMID:19188439
References
Additional References at PubMed
Genomics
QTLs in Region (GRCm38)
11567249 Elorr3_m ethanol induced loss of righting response 3 (mouse) 4 3722677 156183778 Mouse 26884449 Sklq2_m skull length QTL 2, 5 week (mouse) 4 36700000 129100000 Mouse 1357895 Ctrcts_m cataract severity (mouse) Not determined 4 45709925 138615442 Mouse 11532714 Sluc43_m susceptibility to lung cancer 43 (mouse) 4 46642108 123233418 Mouse 4141900 Skts-fp1_m skin tumor susceptibility in FVB and PWK 1 (mouse) Not determined 4 53550839 124161387 Mouse 27095905 Scvln3_m sacral vertebrae length 2, 5 week (mouse) 4 55600000 129100000 Mouse 26884437 Sklq13_m skull length QTL 13, 16 week (mouse) 4 57700000 155600000 Mouse 25314312 Syncl2_m synaptonemal complex length 2 (mouse) 4 65800000 146500000 Mouse 27095917 Scvln14_m sacral vertebrae length 2, 16 week (mouse) 4 68100000 130500000 Mouse 26884445 Sklq7_m skull length QTL 7, 10 week (mouse) 4 68100000 150800000 Mouse 27095924 Pglq2_m pelvic girdle length QTL 2, 5 week (mouse) 4 69200000 131000000 Mouse 1301597 Anxty_m anxiety (mouse) Not determined 4 74219337 128115487 Mouse 4141549 W10q10_m weight 10 weeks QTL 10 (mouse) Not determined 89063832 140740892 Mouse 4141093 W3q17_m weight 3 weeks QTL 17 (mouse) Not determined 89063832 140740892 Mouse 4141623 W6q13_m weight 6 weeks QTL 13 (mouse) Not determined 89063832 140740892 Mouse 1357529 Lvrq8_m liver weight QTL 8 (mouse) Not determined 4 89063832 140740892 Mouse 39128212 Lwq21_m liver weight QTL 21 (mouse) 4 89063832 140740892 Mouse 1301823 Bmd7_m bone mineral density 7 (mouse) Not determined 4 89063832 151570093 Mouse 1300918 Stheal4_m soft tissue heal 4 (mouse) Not determined 4 90112430 124112550 Mouse 11553870 Cmmm_m carcinoma modifier of MSM (mouse) 4 90733471 124733584 Mouse 13208562 Wght7_m weight 7 (mouse) 4 91000000 148000000 Mouse 15039368 Nmrs19_m NAFLD-associated magnetic resonance shift 19 (mouse) 4 91025583 125025583 Mouse 12904002 Opfaq9_m open field activity QTL 9 (mouse) 4 93118593 127118593 Mouse 1301731 Cafq2_m caffeine metabolism QTL 2 (mouse) Not determined 4 94875058 128875257 Mouse 1301233 Sbw2_m splenomegaly-NZB x NZW 2 (mouse) Not determined 4 95069342 128115487 Mouse 1301815 Sles2_m systemic lupus erythmatosus suppressor 2 (mouse) Not determined 4 95069342 150592401 Mouse 1300580 Lbw2_m lupus NZB x NZW 2 (mouse) Not determined 4 98657302 128115487 Mouse 1301106 Skts7_m skin tumor susceptibility 7 (mouse) Not determined 4 100214774 134215009 Mouse 1301847 Fecq2_m fecundity QTL 2 (mouse) Not determined 4 100214774 134215009 Mouse 14696689 Gdq2_m grooming duration QTL 2, females (mouse) 4 101000000 125000000 Mouse 12880433 Fgf23lq1_m FGF23 serum level QTL 1 (mouse) 4 101300000 135300000 Mouse 1300689 Dob1_m Dietary obesity 1 (mouse) Body weight 4 101717404 123233418 Mouse 15039377 Bw45_m body weight QTL 45 (mouse) 4 105812001 139812001 Mouse 15039378 Adip30_m adiposity 30 (mouse) 4 105812001 139812001 Mouse 15039382 Ltgq7_m liver triglyceride QTL 7 (mouse) 4 105812001 139812001 Mouse 12910794 Pwbwq8_m post-weaning body weight QTL 8 (mouse) 4 105978113 141706527 Mouse 12910797 Pwgrq4_m pre-weaning growth rate QTL 4 (mouse) 4 105978113 141706527 Mouse 12910808 Pwbwq9_m post-weaning body weight QTL 9 (mouse) 4 105978113 141706527 Mouse 12910813 Pwbwq4_m pre-weaning body weight QTL 4 (mouse) 4 105978113 141706527 Mouse 1357800 Tgq3_m triglyceride QTL 3 (mouse) Not determined 4 107161300 141161387 Mouse 1300663 Start2_m startle response 2 (mouse) Not determined 4 107371164 141371360 Mouse 1300809 Ccrs2_m corpus callosum hemisphere surface size 2 (mouse) Not determined 4 107371164 141371360 Mouse 1300781 Lith8_m lithogenic gene 8 (mouse) Not determined 4 107371164 141371360 Mouse 1301382 Arvm2_m autoimmune renal vasculitis 2 (mouse) Not determined 4 107897771 141897963 Mouse 10755520 Rbc1_m red blood cell count 1 (mouse) 4 108583899 142583899 Mouse 10755522 Hgb1_m hemoglobin 1 (mouse) 4 108583899 142583899 Mouse 10755521 Hct1_m hematocrit 1 (mouse) 4 108583899 142583899 Mouse 10412072 Ssen1_m suseptibility to Sendai virus 1 (mouse) Not determined 4 109800935 133427471 Mouse 13208565 Bmiq6_m body mass index QTL 6 (mouse) 4 111000000 126000000 Mouse 1300839 Dyscalc2_m dystrophic cardiac calcinosis 2 (mouse) Not determined 4 111115258 145115487 Mouse 1300743 Skull6_m skull morphology 6 (mouse) Not determined 4 111115258 145115487 Mouse 15039385 Mvlq3_m macrovesicular liver lesion QTL 3 (mouse) 4 112288593 146288593 Mouse 4141001 Tgq17_m triglyceride QTL 17 (mouse) Not determined 112629696 146629696 Mouse 10047132 Albq19_m albuminuria QTL 19 (mouse) Not determined 4 112930596 146930596 Mouse 1300655 Nidds_m non-insulin-dependent diabetes mellitus in SJL (mouse) Not determined 4 115173580 129572122 Mouse 1301996 Mmtg2_m modifier of mammary tumor growth 2 (mouse) Not determined 4 116413782 124161387 Mouse 4142493 Femwf13_m femur work to failure 13 (mouse) Not determined 116427367 150427471 Mouse 4141330 Iva1_m isovaleric acid smelling 1 (mouse) Not determined 117214774 120866006 Mouse 1302078 Sluc21_m susceptibility to lung cancer 21 (mouse) Not determined 4 117673830 151673964 Mouse 14746982 Manh56_m mandible shape 56 (mouse) 4 118088606 152088606 Mouse 12903992 Opfaq6_m open field activity QTL 6 (mouse) 4 119207798 121509300 Mouse 1301964 Bw8q2_m body weight at 8 weeks QTL 2 (mouse) Not determined 4 120137122 154137225 Mouse 1302102 Bis1_m beta-carboline-induced seizures 1 (mouse) Not determined 4 120137122 154137225 Mouse